Original Research

Published on 24 Nov 2022

Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition

in Neuropharmacology

Guanglin Liu
Ruiyan Wang
Huan Chen
Ping Wu
Yaning Fu
Kaixin Li
Mingda Liu
Zhihao Shi
Yuan Zhang
Yue Su

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1058254

4,382 views
2 citations

Original Research

Published on 24 Nov 2022

The anterior cingulate cortex contributes to the analgesic rather than the anxiolytic effects of duloxetine in chronic pain-induced anxiety

in Neuropharmacology

Chenglin Li
Kaiji Ni
Meiru Qi
Jie Li
Kexin Yang
Yanli Luo

Frontiers in Neuroscience

doi 10.3389/fnins.2022.992130

2,407 views
1 citation

Editorial

Published on 21 Nov 2022

Editorial: The role of monoamine oxidase inhibition in smokers: Toward understanding their potential effects in reinforcing nicotine dependence

in Neuropharmacology

Penelope Truman

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1094549

1,033 views

Original Research

Published on 16 Nov 2022

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

in Neuropharmacology

Yunzhu Liu
Shiyong Li
Dongdong Hao
Zhongping Zhang
Yongxin Yi
Jiayang Fang
Weizhi Lin
Min Zhang

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1026127

2,820 views
3 citations

Review

Published on 15 Nov 2022

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

in Neuropharmacology

Anwesha Gangopadhyay
Radwa Ibrahim
Karli Theberge
Meghan May
Karen L. Houseknecht

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1042442

14,638 views
15 citations

Original Research

Published on 10 Nov 2022

Regulation of neural stem cell proliferation and survival by protein arginine methyltransferase 1

in Neuropharmacology

Misuzu Hashimoto
Kaho Takeichi
Kazuya Murata
Aoi Kozakai
Atsushi Yagi
Kohei Ishikawa
Chiharu Suzuki-Nakagawa
Yoshitoshi Kasuya
Akiyoshi Fukamizu
Tsutomu Nakagawa

Frontiers in Neuroscience

doi 10.3389/fnins.2022.948517

4,256 views
3 citations

Review

Published on 10 Nov 2022

East Wind, West Wind: Toward the modernization of traditional Chinese medicine

in Neuropharmacology

Ernesto Yagüe
He Sun
Yunhui Hu

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1057817

8,664 views
14 citations

Original Research

Published on 10 Nov 2022

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease

in Neuropharmacology

Ha Young Jang
Jung Mi Oh
In-Wha Kim

Frontiers in Neuroscience

doi 10.3389/fnins.2022.989174

3,851 views
5 citations

Original Research

Published on 04 Nov 2022

Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

in Neuropharmacology

Abhinav Anand
Navneet Khurana
Nemat Ali
Abdullah F. AlAsmari
Metab Alharbi
Mohammad Waseem
Neha Sharma

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1005972

4,574 views
8 citations

Review

Published on 03 Nov 2022

Signaling underlying kappa opioid receptor-mediated behaviors in rodents

in Neuropharmacology

Lee-Yuan Liu-Chen
Peng Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2022.964724

3,836 views
6 citations

Editorial

Published on 31 Oct 2022

Editorial: Immune and oxidative pathways in psychiatric disorders

in Neuropharmacology

Angela Maria Casaril

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1073757

1,220 views
1 citation

Review

Published on 26 Oct 2022

Missing pieces in decoding the brain oxytocin puzzle: Functional insights from mouse brain wiring diagrams

in Neuropharmacology

Steffy B. Manjila
Rebecca Betty
Yongsoo Kim

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1044736

4,480 views
8 citations

Original Research

Published on 25 Oct 2022

Oro-mucosal administration of oxytocin using medicated lollipops alters social attention, similar to intranasal and lingual routes: Implications for therapeutic use

in Neuropharmacology

Dan Xu
Qin Li
Qian Zhuang
Yingying Zhang
Shuxia Yao
Weihua Zhao
Keith M. Kendrick

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1022101

2,578 views
7 citations

Review

Published on 20 Oct 2022

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial

in Neuropharmacology

Halit Yusuf Altay
Fatma Ozdemir
Ferdows Afghah
Zeynep Kilinc
Mehri Ahmadian
Markus Tschopp
Cavit Agca

Frontiers in Neuroscience

doi 10.3389/fnins.2022.924917

5,474 views
5 citations

Review

Published on 19 Oct 2022

The use of attention-deficit hyperactivity disorder medications in cardiac disease

in Neuropharmacology

Constantin-Cristian Topriceanu
James C. Moon
Gabriella Captur
Bhathika Perera

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1020961

30,087 views
7 citations

Original Research

Published on 18 Oct 2022

Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease

in Neuropharmacology

Laura Borgstedt
Sebastian Bratke
Manfred Blobner
Christoph Pötzl
Bernhard Ulm
Bettina Jungwirth
Sebastian Schmid

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1033729

2,521 views
3 citations

Navigation group

Articles

Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition

The anterior cingulate cortex contributes to the analgesic rather than the anxiolytic effects of duloxetine in chronic pain-induced anxiety

Editorial: The role of monoamine oxidase inhibition in smokers: Toward understanding their potential effects in reinforcing nicotine dependence

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

Regulation of neural stem cell proliferation and survival by protein arginine methyltransferase 1

East Wind, West Wind: Toward the modernization of traditional Chinese medicine

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease

Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

Signaling underlying kappa opioid receptor-mediated behaviors in rodents

Editorial: Immune and oxidative pathways in psychiatric disorders

Missing pieces in decoding the brain oxytocin puzzle: Functional insights from mouse brain wiring diagrams

Oro-mucosal administration of oxytocin using medicated lollipops alters social attention, similar to intranasal and lingual routes: Implications for therapeutic use

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial

The use of attention-deficit hyperactivity disorder medications in cardiac disease

Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease